ArticleInternational journal of molecular sciences2017

A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells.

Anna M Serwotka-Suszczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.